Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS)
Authors:
- Michelle RussellMRMichelle Russell
- Vitali PoolVPVitali Pool
- John M. KelsoJKJohn M. Kelso
- Vesna J. Tomazic-JezicVTVesna J. Tomazic-Jezic
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Monitoring the Safety of VaccinesDrug Safety, 2002
- Enhancing Vaccine Safety Surveillance: A Capture-Recapture Analysis of Intussusception after Rotavirus VaccinationAmerican Journal of Epidemiology, 2001
- Natural rubber pharmaceutical vial closures release latex allergens that produce skin reactionsJournal of Allergy and Clinical Immunology, 2001
- An overview of the vaccine adverse event reporting system (VAERS) as a surveillance systemVaccine, 1999
- The prevalence of anti-latex IgE antibodies in 1000 volunteer blood donorsJournal of Allergy and Clinical Immunology, 1996
- The Safety of Acellular Pertussis Vaccine vs Whole-Cell Pertussis VaccineArchives of Pediatrics & Adolescent Medicine, 1996
- Latex Allergy and Plastic SyringesAnesthesia & Analgesia, 1996
- Local Reaction Secondary to Insulin Injection: A potential role for latex antigens in insulin vials and syringesDiabetes Care, 1995
- Anaphylaxis after hepatitis B vaccinationThe Lancet, 1995
- The vaccine adverse event reporting system (VAERS)Vaccine, 1994